Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE

Type C hepatic encephalopathy (HE) is a neuropsychiatric disease caused by chronic liver disease. Management of type C HE remains an important challenge because treatment options are limited. Both the antibiotic rifaximin and probiotics have been reported to reduce the symptoms of HE, but longitudin...

Descripción completa

Detalles Bibliográficos
Autores principales: Flatt, Emmanuelle, McLin, Valérie A., Braissant, Olivier, Pierzchala, Katarzyna, Mastromarino, Paola, Mitrea, Stefanita-Octavian, Sessa, Dario, Gruetter, Rolf, Cudalbu, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429411/
https://www.ncbi.nlm.nih.gov/pubmed/34504135
http://dx.doi.org/10.1038/s41598-021-97018-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429411/
https://www.ncbi.nlm.nih.gov/pubmed/34504135
http://dx.doi.org/10.1038/s41598-021-97018-8

Ejemplares similares